Eads & Heald Wealth Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
Eads & Heald Wealth Management's AGN Position: Q4 2017 in Review
Eads & Heald Wealth Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 995 shares — an estimated $204K sold.
Eads & Heald Wealth Management first reported a position in AGN in Q2 2013 and held it in 18 quarters. The position peaked at $2.61M in Q1 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.
- Eads & Heald Wealth Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
- Eads & Heald Wealth Management sold 995 Allergan plc shares in Q4 2017, an estimated $204K.
- Eads & Heald Wealth Management first reported a position in Allergan plc in Q2 2013 and held it in 18 quarters.
- Eads & Heald Wealth Management's Allergan plc position peaked at $2.61M in Q1 2015.
- 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.
Based on Eads & Heald Wealth Management's 13F filing for Q4 2017, filed 31 Jan 2018.